Antithrombin III supplementation during neonatal and pediatric extracorporeal membrane oxygenation.

Noy Meshulami,Robert Green,Shubhi Kaushik

Artificial organs（2023）

引用 0|浏览4

暂无评分

摘要

AT3 administration was associated with increased rates of daily bleeding, a hypothesized potential complication of AT3 supplementation. In addition, AT3 supplementation did not result in lower rates of thrombosis. We recommend clinicians utilize caution when considering supplementing patients on ECMO with exogenous AT3.

查看译文

关键词

anticoagulation, antithrombin III, ECMO, NICU, pediatric cardiac ICU, PICU

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要